Navigation Links
Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
Date:2/12/2008

brighter the sun, the darker they get -- getting as dark as sunglasses, providing protection in bright, glaring light. Since Transitions lenses darken only as much as needed, they can be worn comfortably year-round to provide convenience and 100 percent automatic UVA/UVB and glare protection every day -- sunny, cloudy or in between.

For more information about the company and Transitions lenses, the first to earn the American Optometric Association's Seal of Acceptance for Ultraviolet Absorbers/Blockers, visit Transitions.com or contact Transitions Optical Customer Service at (800) 848-1506 (United States) or (877) 254-2590 (Canada).


'/>"/>
SOURCE Transitions Optical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Optical scientist honored for understanding and improving vision
2. Minority patients prefer optical colonoscopy for colorectal cancer screening
3. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
4. Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results
5. Optical Coherence Tomography Market to Top $800 Million by 2012
6. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
7. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
8. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
9. Vitasoy Promotes the Soy Breast Health Connection
10. AvMed Promotes Kirk Cianciolo to Senior Vice President and Chief Medical Officer
11. Lifespring Health Promotes Health and Fitness by Sponsoring Silicon Valley Marathon on November 3rd and 4th
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 1Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 2Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 3Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 1Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 2Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 1Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 2Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 3